Approved, Seladelpar Can Provide an Important Treatment Option for People Living With the Rare Liver Disease in the European Economic Area – ...

Stockholm, Sweden Saturday, February 22, 2025, 09:00 Hrs [IST] ...

Gilead Sciences (GILD) said on Friday that the European Commission (EC) granted conditional marketing authorization for ...

On the downside, the US Dollar Index may test the lower boundary of the descending channel at 106.10, followed by the key psychological level of 106.00. A break below this critical support zone could ...

While Health Technology Assessment agencies anticipate that joint efforts and harmonisation will enhance evaluations’ efficiency, tangible evidence is taking time to materialise.

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best ...

Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old ...

This contract has experienced an incredible rally since Jan. 22, however, the forward curve is pointing sharply downwards ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.